We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Sandoz Accuses Eli Lilly Of Inequitable Conduct

Law360 (October 12, 2007, 12:00 AM EDT) -- Generic pharmaceutical company Sandoz Inc. is fighting back against Eli Lilly & Co. in an infringement battle over a patent for attention-deficit hyperactivity disorder treatment Strattera, denying the drug maker’s claims...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.